KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Equity Income (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Equity Income for 17 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Equity Income rose 40.0% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.0 million through Dec 2025, up 121.05% year-over-year, with the annual reading at $42.0 million for FY2025, 121.05% up from the prior year.
  • Equity Income hit $7.0 million in Q4 2025 for Quest Diagnostics, down from $8.0 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $31.0 million in Q1 2022 to a low of $3.0 million in Q4 2022.
  • Historically, Equity Income has averaged $11.0 million across 5 years, with a median of $8.0 million in 2023.
  • Biggest five-year swings in Equity Income: crashed 88.0% in 2022 and later skyrocketed 166.67% in 2023.
  • Year by year, Equity Income stood at $25.0 million in 2021, then plummeted by 88.0% to $3.0 million in 2022, then surged by 166.67% to $8.0 million in 2023, then tumbled by 37.5% to $5.0 million in 2024, then skyrocketed by 40.0% to $7.0 million in 2025.
  • Business Quant data shows Equity Income for DGX at $7.0 million in Q4 2025, $8.0 million in Q3 2025, and $9.0 million in Q2 2025.